Paul A. Fishman
Group Health Research Institute
74 Papers
590 Citations
Paul A. Fishman is an academic researcher from Group Health Research Institute. The author has contributed to research in topics: Health care & Medicine. The author has an hindex of 35, co-authored 72 publications. Previous affiliations of Paul A. Fishman include Group Health Cooperative & University of Washington.
Chat about Author
Papers
Effectiveness of Home Blood Pressure Monitoring, Web Communication, and Pharmacist Care on Hypertension Control: A Randomized Controlled Trial
Beverly B. Green,Andrea J. Cook,James D. Ralston,James D. Ralston,Paul A. Fishman,Sheryl L. Catz,James A. Carlson,David Carrell,Lynda Tyll,Eric B. Larson,Robert S. Thompson,Robert S. Thompson +11 more
TL;DR: Pharmacist care management delivered through secure patient Web communications improved BP control in patients with hypertension.
664
The Group Health Medical Home At Year Two: Cost Savings, Higher Patient Satisfaction, And Less Burnout For Providers
Robert J. Reid,Katie Coleman,Eric Johnson,Paul A. Fishman,Clarissa Hsu,Michael P. Soman,Claire E. Trescott,Michael Erikson,Eric B. Larson +8 more
TL;DR: The results show improvements in patients' experiences, quality, and clinician burnout through two years, and an operational blueprint and policy recommendations for adoption in other health care settings are offered.
630
Risk Adjustment Using Automated Ambulatory Pharmacy Data: The RxRisk Model
Paul A. Fishman,Michael J. Goodman,Mark C. Hornbrook,Richard T. Meenan,Donald J. Bachman,Maureen C. O'Keeffe Rosetti +5 more
TL;DR: HCCs produce more accurate forecasts of total cost, but the pharmacy-based RxRisk is an alternative risk assessment instrument to several diagnostic based models and depending on the nature of the application may be a more appropriate option for medical risk analysis.
372
Healthcare Utilization and Costs for Women with a History of Intimate Partner Violence.
Frederick P. Rivara,Melissa L. Anderson,Paul A. Fishman,Amy E. Bonomi,Robert J. Reid,David Carrell,Robert S. Thompson +6 more
TL;DR: Women with a history of IPV had significantly higher healthcare utilization and costs, continuing long after IPV ended, and efforts to prevent its occurrence and consequences are clearly indicated.
363
Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument.
Kevin L. Sloan,Anne E. Sales,Anne E. Sales,Chuan Fen Liu,Chuan Fen Liu,Paul A. Fishman,Paul A. Fishman,Paul Nichol,Paul Nichol,Norman T. Suzuki,Norman T. Suzuki,Nancy D. Sharp,Nancy D. Sharp +12 more
TL;DR: The RxRisk-V provides a reliable and valid method for administrators to describe and understand better chronic disease burden of their treated populations and Tailoring to the VHA permits assessment of disease burden specific to this population.
243